UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): May 10, 2016

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

ITEM 5.07 Submission of Matters to a Vote of Security Holders. 

On May 10, 2016 Second Sight Medical Products Inc. ("Second Sight" or "Company") held its annual meeting of stockholders in Valencia, California. At the annual meeting, there were 36,019,086 shares of Second Sight's common stock entitled to vote, and 30,161,225 shares of Second Sight's common stock (83.74%) were represented at the meeting in person or by proxy. The following are the voting results on each matter submitted to the stockholders of Second Sight at the annual meeting of stockholders. The proposals acted upon by the stockholders are described in detail in Second Sight's Proxy Statement which was filed with the Securities and Exchange Commission on April 15, 2016.

Proposal 1: The stockholders elected each of the six director nominees to the Board of Directors of the Company to serve until the 2017 Annual Meeting of Stockholders and until his successor has been duly elected and qualifies, as follows:

Proposal 2: The stockholders approved amendments to the 2011 Equity Incentive Plan (“Plan”) to (i) increase the maximum number of shares of common stock that may be issued under the Plan by 1,500,000 shares – from 6,000,000 shares to 7,500,000 shares; (ii) add the ability for the Company to grant restricted stock units (“RSUs”) under the Plan; and (iii) permit the Company, at any time in its discretion, to reprice or exchange outstanding options under the Plan, as follows:

Proposal 3: The stockholders ratified the appointment of Gumbiner Savett Inc. as Second Sight’s independent registered public accounting firm for the year ending December 31, 2016, as follows:

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 10, 2016

SECOND SIGHT MEDICAL PRODUCTS, INC.